CD44: A Sensor of tissue damage critical for restoring homeostasis

Extracellular Matrix: Pathobiology and Signaling

Volumn , Issue , 2012, Pages 484-498

  Puré, Ellen ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957861618     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Acharya, P. S., Majumdar, S., Jacob, M., et al. (2008). Fibroblast migration is mediated by CD44-dependent TGFbeta activation. J Cell Sci 121, 1393-1402.
2. Asao, T., Nakamura, J., Shitara, Y., et al. (2000). Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma. Dis Colon Rectum 43, 1250-1255.
3. Bourguignon, L. Y., Singleton, P. A., Zhu, H., and Diedrich, F. (2003). Hyaluronan-mediatedCD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem 278, 29420-29434.
4. Bourguignon, L. Y., Zhu, H., Shao, L., and Chen, Y. W. (2000). CD44 interaction with Tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem 275, 1829-1838.
5. Camp, R. L., Kraus, T. A., and Pure, E. (1991). Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. J Cell Biol 115, 1283-1292.
6. Cheng, C., Yaffe, M. B., and Sharp, P. A. (2006). A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 20, 1715-1720.
7. Cichy, J., Bals, R., Potempa, J., Mani, A., and Pure, E. (2002). Proteinase-mediated release of epithelial cell-associated CD44: extracellular CD44 complexes with components of cellular matrices. J Biol Chem 277, 44440-44447.
8. Cichy, J., and Pure, E. (2003). The liberation of CD44. J Cell Biol 161, 839-843.
9. Clark, R. A., Alon, R., and Springer, T. A. (1996). CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 134, 1075-1087.
10. Cuff, C. A., Kothapalli, D., Azonobi, I., et al. (2001). The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest 108, 1031-1040.
11. Culty, M., Nguyen, H. A., and Underhill, C. B. (1992). The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 116, 1055-1062.
12. Culty, M., O'Mara, T. E., Underhill, C. B., Yeager, H., Jr, and Swartz, R.P. (1994). Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages. J Leukoc Biol 56, 605-611.
13. DeGrendele, H. C., Estess, P., Picker, L. J., and Siegelman, M. H. (1996). CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 183, 1119-1130.
14. DeGrendele, H. C., Estess, P., and Siegelman, M. H. (1997a). Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278, 672-675.
15. DeGrendele, H. C., Kosfiszer, M., Estess, P., and Siegelman, M. H. (1997b). CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 159, 2546-2553.
16. Gee, K., Kryworuchko, M., and Kumar, A. (2004). Recent advances in the regulation of CD44 expression and its role in inflammation and autoimmune diseases. Arch Immunol Ther Exp (Warsz) 52, 13-26.
17. Gumireddy, K., Sun, F., Klein-Szanto, A. J., et al. (2007). In vivo selection for metastasis promoting genes in the mouse. Proc Natl Acad Sci U S A 104, 6696-6701.
18. Hamilton, S. R., Fard, S. F., Paiwand, F. F., et al. (2007). The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. J Biol Chem 282 (22), 16667-16680.
19. Hart, S. P., Dougherty, G. J., Haslett, C., and Dransfield, I. (1997). CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J Immunol 159, 919-925.
20. Henke, C. A., Roongta, U., Mickelson, D. J., Knutson, J. R., and McCarthy, J. B. (1996). CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest 97, 2541-2552.
21. Hirano, H., Screaton, G. R., Bell, M. V., Jackson, D. G., Bell, J. I., and Hodes, R. J. (1993). CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. Int Immunol 6, 49-59.
22. Hodge-Dufour, J., Noble, P. W., Horton, M. R., et al. (1997). Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 159, 2492-2500.
23. Huang, Q., Gumireddy, K., Schrier, M., et al. (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10, 202-210.
24. Ilangumaran, S., Borisch, B., and Hoessli, D. C. (1999). Signal transduction via CD44: role of plasma membrane microdomains. Leuk. Lymphoma 35, 455-469.
25. Isacke, C. M. (1994). The role of cytoplasmic domain in regulating CD44 function. J Cell Sci 107, 2353-2359.
26. Ishiwatari-Hayasaka, H., Fujimoto, T., Osawa, T., Hirama, T., Toyama-Sorimachi, N., and Miyasaka, M. (1999). Requirements for signal delivery through CD44: analysis using CD44-Fas chimeric proteins. J Immunol 163, 1258-1264.
27. Jalkanen, S., and Jalkanen, M. (1992). Lymphocyte CD44 binds the COOH-terminal heparinbinding domain of fibronectin. J Cell Biol 1 16, 817-825.
28. Kawana, H., Karaki, H., Higashi, M., et al. (2008). CD44 suppresses TLR-mediated inflammation. J Immunol 180, 4235-4245.
29. Keski-Oja, J., Koli, K., and von Melchner, H. (2004). TGF-beta activation by traction? Trends Cell Biol 14, 657-659.
30. Kohda, D., Morton, C. J., Parkar, A. A., et al. (1996). Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 86, 767-775.
31. Kothapalli, D., Flowers, J., Xu, T., Pure, E., and Assoian, R. K. (2008). Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. J Biol Chem 283, 31823-31829.
32. Kothapalli, D., Zhao, L., Hawthorne, E. A., et al. (2007). Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells. J Cell Biol 176, 535-544.
33. Lammich, S., Okochi, M., Takeda, M., et al. (2002). Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J Biol Chem 277, 44754-44759.
34. Lesley, J., English, N., Charles, C., and Hyman, R. (2000). The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding. Eur J Immunol 30, 245-53.
35. Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R., and Kincade, P. W. (1992). Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med 175, 257-266.
36. Lesley, J., Hyman, R., English, N., Catterall, J. B., and Turner, G. A. (1997). CD44 in inflammation and metastasis. Glycoconj J 14, 611-622.
37. Lesley, J., Hyman, R., and Kincade, P. W. (1993). CD44 and its interaction with extracellular matrix. Adv Immunol 54, 271-335.
38. Levesque, M. C., and Haynes, B. F., (1997). Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. J Immunol 159, 6184-6194.
39. Li, M. O., and Flavell, R. A. (2008). Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28, 468-476.
40. Liang, J., Jiang, D., Griffith, J., et al. (2007). CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol 178, 2469-2475.
41. Liu, C., Kelnar, K., Liu, B., et al. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17, 211-215.
42. Lopez, J. I., Camenisch, T. D., Stevens, M. V., Sands, B. J., McDonald, J., and Schroeder, J. A. (2005). CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res 65, 6755-6763.
43. Margadant, C., and Sonnenberg, A. (2010). Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 1 1, 97-105.
44. Martin-Villar, E., Fernandez-Munoz, B., Parsons, M., et al. (2010). Podoplanin associates with CD44 to promote directional cell migration. Mol Biol Cell 21, 4387-4399.
45. Mohamadzadeh, M., DeGrendele, H., Arizpe, H., Estess, P., and Siegelman, M. (1998). Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 101, 97-108.
46. Morrison, H., Sherman, L. S., Legg, J., et al. (2001). The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15, 968-980.
47. Mrass, P., Kinjyo, I., Ng, L. G., Reiner, S. L., Puré, E., and Weninger, W. (2008). CD44 mediates successful interstitial navigation by killer T cells and enables efficient antitumor immunity. Immunity 29, 971-985.
48. Munger, J. S., Huang, X., Kawakatsu, H., et al. (1996). The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328.
49. Nagano, O., and Saya, H. (2004). Mechanism and biological significance of CD44 cleavage. Cancer Sci 95, 935.
50. Naor, D., Sionov, R. V., and Ish-Shalom, D. (1997). CD44: structure, function, and association with the malignant process. Adv Cancer Res 71, 241-319.
51. Okamoto, I., Kawano, Y., Murakami, D., et al. (2001). Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 255, 755-762.
52. Okamoto, I., Kawano, Y., Tsuiki, H., et al. (1999). CD44 cleavage induced by a membraneassociated metalloprotease plays a critical role in tumor cell migration. Oncogene 18, 1435-1446.
53. Oliferenko, S., Kaverina, I., Small, J. V., and Huber, L. A. (2000). Hyaluronic acid (HA) binding to CD44 activates Rac1 and induces lamellipodia outgrowth. J Cell Biol 148, 1159-1164.
54. Ponta, H., Sherman, L., and Herrlich, P. A. (2003). CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4, 33-45.
55. Puré, E. (2006). Role of CD44 in atherogenesis and its potential role as a therapeutic target. In Advances in Translational Medicine: Lipids and Atherosclerosis, C. J. Packard and D. J. Rader, eds., 191-206. London: Taylor and Francis Medical Publishing.
56. Puré, E., and Assoian, R. K. (2009). Rheostatic signaling by CD44 and hyaluronan. Cell Signal 21, 651-655.
57. Puré, E., Camp, R. L., Peritt, D., Panettieri, R. A., Jr, Lazaar, A. L., and Nayak, S. (1995). Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 181, 55-62.
58. Puré, E., and Cuff, C. A. (2001). A crucial role for CD44 in inflammation. Trends Mol Med 7, 213-221.
59. Screaton, G. R., Bell, M. V., Jackson, F. B., Gerth, U., and Bell, J. I. (1992). Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 89, 12160-12164.
60. Siegelman, M. H., DeGrendele, H. C., and Estess, P. (1999). Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 66, 315-321.
61. Sleeman, J., Rudy, W., Hofmann, M., Moll, J., Herrlich, P., and Ponta, H. (1996). Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol 135, 1139-1150.
62. Stamenkovic, I., and Yu, Q. (2010). Merlin, a "Magic" linker between the extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival. Curr Protein Pept Sci 11, 471-484.
63. Taher, T. E., Smit, L., Griffioen, A. W., Schilder-Tol, E. J., Borst, J., and Pals, S. T. (1996). Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J Biol Chem 271, 2863-2867.
64. Teder, P., Vandivier, R. W., Jiang, D., et al. (2002). Resolution of lung inflammation by CD44. Science 296, 155-158.
65. Underhill, C. B., Nguyen, H. A., Shizari, M., and Culty, M. (1993). CD44 positive macrophages take up hyaluronan during lung development. Dev Biol 155, 324-336.
66. van der Voort, R., Taher, T. E., Wielenga, V. J. M., et al. (1999). Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem 274, 6499-6506.
67. Vigetti, D., Viola, M., Karousou, E., et al. (2008). Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J Biol Chem 283, 4448-4458.
68. Weber, G. F., Ashkar, S., Glimcher, M. J., and Cantor, H. (1996). Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271, 509-512.
69. Wipff, P. J., and Hinz, B. (2008). Integrins and the activation of latent transforming growth factor [beta]1 - an intimate relationship. Eur J Cell Biol 87, 601-615.
70. Xu, Y., Stamenkovic, I., and Yu, Q. (2010). CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res 70, 2455-2464.
71. Yu, Q., and Stamenkovic, I. (1999). Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13, 35-48.
72. Yu, Q., and Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14, 163-176.
73. Zhao, L., Hall, A., Levenkova, N., et al. (2007). CD44 regulates vascular gene expression in a proatherogenic environment. Arterioscler Thromb Vasc Biol 27, 886-892.
74. Zhao, L., Lee, E., Zukas, A. M., et al. (2008). CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in apoE-deficient mice. Arterioscler Thromb Vasc Biol 28, 1283-1289.